Business Wire

Swiss Wearable Brand MyKronoz Announces Availability of ZeTime Petite Hybrid Smartwatch at CES 2018

Jaa

Following a historic crowdfunding campaign raising more than $6 million on Kickstarter and Indiegogo last year, MyKronoz, the premier watchmaking brand for the smart generation, today announced the global availability of its ZeTime Petite hybrid smartwatch. Both ZeTime Petite (39mm) and Regular (44mm) will be on display and available for demos at CES 2018 January 9-12 in Las Vegas.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180104005661/en/

MyKronoz ZeTime Petite & Regular

MyKronoz ZeTime Petite & Regular

The world's first hybrid smartwatch with mechanical hands over a color touchscreen, ZeTime offers the classic design of a Swiss timepiece with most advanced features of a smartwatch. MyKronoz’s proprietary ‘Smart Movement’ technology enables ZeTime’s always-on hands to function for up to 30 days with a single charge, ensuring the primary function of the watch – to tell time – is always running. With a retail price starting at $199, the hybrid device is now available in two different sizes (39mm and 44mm) and three collections comprising a variety of watch case finishing and bands, to appeal to a wide audience.

“MyKronoz wants to set a new standard in both the watchmaking and wearable industries. With ZeTime, we have created the first smartwatch with no compromises, bringing the best of Swiss design and expertise into a wearable device” said Boris Brault, CEO and founder of MyKronoz. “As we pursue our ambition to become tomorrow’s leader in new generation of watches with attractive price positioning and innovative technologies, we are beyond excited and proud to present our game-changing product line at CES 2018.”

Proof of its bold and ambitious strategy, MyKronoz ZeTime was supported by more than 35,000 backers, becoming the most funded hybrid smartwatch, the largest campaign ever from a European company and the most backed product of the whole year 2017. Today, ZeTime continues to have an engaged following across online communities and will be massively promoted by early 2018 in retail across more than 60 countries.

Boasting a 1.05-inch TFT color touchscreen for the Petite version, and 1.22-inch for the Regular, MyKronoz is now one of the only wearable brands to offer a smartwatch with two display and case sizes, a key attribute to drive large scale adoption.

ZeTime is packed with advanced, easy-to-use features for any consumer.
Using the color touchscreen and smart crown intuitive navigation, users can control their phone’s functions right from their wrist: read notifications, view incoming calls, check weather forecasts, control music, take a photo, and more. Enhancing the user experience, ZeTime’s proprietary smart movement technology automatically adjusts the hands position to maximize screen visibility when reading notifications content. The hybrid device is also equipped with an optical heart-rate sensor and 3-axis accelerometer to track daily activity and sleep.

Designed to be worn all day everyday, ZeTime is water resistant to ATM 5, comes in a sleek stainless steel watch case, sapphire glass, and a variety of interchangeable bands and customizable watch faces. ZeTime seamlessly connects via Bluetooth with both Android and iOS phones (Android 5.0+ or iOS 8.0 and above).

The MyKronoz ZeTime Petite will be making its debut at CES Unveiled on Sunday January 7, 2018 at Mandalay Bay. ZeTime Petite and the ZeTime Regular hybrid smartwatches will also be on display and available for demos at Pepcom Digital Experience! on Monday, January 8, 2018 at The Mirage; and on the CES 2018 showfloor at the MyKronoz booth in the Sands Expo (Booth #42511) January 9-12, 2018.

Tech Specs (Sizes: [R] Regular – [P] Petite)

  • Material: stainless steel, sapphire glass
  • Bluetooth: BLE 4.2
  • Watch case dimensions: [R] 44 x 12.8 mm – [P] 39 x 12.6 mm
  • Watch band dimensions: [R] 22 mm – [P] 18 mm
  • Weight: [R] 90g – [P] 80g
  • Battery type: Li-iOn [R] 200 mAh – [P] 180 mAh
  • Battery life: up to 30 days (analog mode) / 3 days (smartwatch mode)
  • Charging system: contact charging
  • Display type: TFT Color touchscreen with hole
  • Display: [R] 1.22 in / 240*240 px – [P] 1.05 in / 240*240 px
  • Sensors: 3-axis accelerometer, optical heart rate
  • Water resistance: 5 ATM
  • Compatibility: iOS 8+ and Android 5.0+

About MyKronoz

Founded in January 2013, MyKronoz is a Swiss company based in Geneva that designs and develops wearable devices intended to improve increasingly mobile, connected and digital lifestyles. MyKronoz strives to expand and facilitate the mobile-user experience with stylish, intuitive and functional techcessories. Now present in more than 40 countries, carried by major retailers and partners worldwide: Amazon, Orange, Auchan, Carrefour, Best Buy, Walmart, Yodobashi, HMV, MyKronoz offers a full range of connected devices spanning across 4 product categories: activity trackers, smartwatches, hybrid smartwatches and watch phones. With a unique DNA mixing mobile tech and fashion, MyKronoz’s goal is to cater to the needs and tastes of the world’s most various user types thanks to a full iOS and Android compatibility at an affordable price. For more information, visit www.mykronoz.com or follow @mykronoz on Twitter.

Contact information

MyKronoz
Annabel Corlay
press@mykronoz.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Manchester United and True Religion Launch Denim Range19.10.2018 20:37Tiedote

Manchester United (NYSE:MANU) and luxury denim brand True Religion have collaborated to launch a range of premium club branded denim wear. A first for the club, the new global partnership with the iconic American denim brand will see a range of men’s & women’s co-branded styles go on sale beginning 26th October in the club’s Megastore as well as online via United Direct and truereligion.com & eu.truereligion.com. The exclusive collection features jeans, shirts and jackets, including a highly desirable limited edition denim jacket embroidered with the club’s crest. Fans will have the opportunity to win a selection of clothing from the new range by visiting www.manutd.com/truereligion. Manchester United’s Group Managing Director, Richard Arnold, comments: “True Religion is a well-known, established name in fashion, creating unique designs without compromising on quality. The range we have collaborated on includes the same attention to detail and craftsmanship that has made True Religion

Arch Insurance Announces Strategic Leadership Changes19.10.2018 16:10Tiedote

Arch Insurance today announced that Matt Shulman will assume the newly created role of CEO, Arch Insurance North America, effective January 1, 2019. In this role, he will lead Arch Insurance’s operations in the United States and Canada. He will report to Nicolas Papadopoulo, Chairman and CEO of Arch Worldwide Insurance Group. Mr. Shulman, who has more than 20 years of experience in the insurance industry, has been with Arch Insurance since 2009 and has served as the President and CEO of Arch Insurance Europe since 2016. “Matt brings significant U.S. and international experience to this role. Under his leadership, together with our senior team, Arch Insurance will continue to enhance our value proposition to our customers through a robust, diversified product portfolio, creative solutions and excellent service,” Mr. Papadopoulo said. Arch Insurance has also created a new organizational structure with three Chief Underwriting Officers (CUO) dedicated to specific lines of business. These

Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer19.10.2018 15:00Tiedote

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that intracranial efficacy data from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of BrigAtinib in 1 st Line) trial showed improved intracranial progression-free survival (PFS) and intracranial objective response rate (ORR) with ALUNBRIG (brigatinib) compared to crizotinib among anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC) patients. Data for these secondary endpoints will be presented in a poster discussion at the European Society for Medical Oncology (ESMO) 2018 Congress on Friday, October 19 at 2:00 p.m. CET in Munich, Germany. These results further support ALUNBRIG as a potential treatment for adults with ALK+ locally advanced or metastatic NSCLC who had not received a prior ALK inhibitor. ALUNBRIG is currently not approved as first-line therapy for advanced ALK+ NSCLC. “ALK+ NSCLC often spreads to the brain, so having options that can clearly demonstrate efficacy both in the brain an

Vertex Receives European CHMP Positive Opinion for KALYDECO® (ivacaftor) to Treat Patients With Cystic Fibrosis Aged 12 to <24 months With Certain Mutations in the CFTR Gene19.10.2018 14:54Tiedote

Vertex Pharmaceuticals (Europe) Limited today announces that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for KALYDECO® (ivacaftor) to include the treatment of people with cystic fibrosis (CF) aged 12 to <24 months who have at least one of the following nine mutations in their cystic fibrosis transmembrane conductance regulator (CFTR) gene: G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. If the European Commission issues a favorable adoption of the EMA CHMP opinion for the extension of indication, ivacaftor will be the first and only medicine approved in Europe to treat the underlying cause of CF in patients aged 12 to <24 months, who have specific mutations in the CFTR gene. “Cystic fibrosis is a chronic, progressive disease that is present at birth, with symptoms often occurring in infancy, so early treatment is crucial to deliver the best possible outcomes for patients,” said Reshma Kewalr

Tradeshift Announces Q3 2018 Results19.10.2018 14:00Tiedote

Tradeshift, the leader in supply chain payments and marketplaces, today announced results from the third quarter of 2018, marking the tenth quarter in a row of successive growth and beating targets. Tradeshift’s third quarter growth stats announced today include: YoY revenue grew 400 percent (trailing 12 months) YoY new bookings grew 284 percent YoY gross merchandise volume (GMV) grew 262 percent New total contract value grew by $47M in Q3 Tradeshift’s customer roster continued strong growth this quarter adding 27 new customers, including Hertz, Shiseido, ECU, and Fortune 500 leaders in retail apparel, agriculture, engineering and construction, hospitality, travel and food delivery. Tradeshift also expanded its app ecosystem by adding a key partnership with Coface, a global credit insurer. Coface has announced a new app solution on the Tradeshift platform offering risk and business information services to help businesses make decisions by ensuring greater financial transparency between

Schlumberger Announces Third-Quarter 2018 Results19.10.2018 14:00Tiedote

Schlumberger Limited (NYSE: SLB) today reported results for the third quarter of 2018. (Stated in millions, except per share amounts) Three Months Ended Change Sept. 30, 2018 Jun. 30, 2018 Sept. 30, 2017 Sequential Year-on-year Revenue $8,504 $8,303 $7,905 2% 8% Pretax operating income $1,152 $1,094 $1,059 5% 9% Pretax operating margin 13.5% 13.2% 13.4% 36 bps 15 bps Net income - GAAP basis $644 $430 $545 50% 18% Net income, excluding charges & credits* $644 $594 $581 8% 11% Diluted EPS - GAAP basis $0.46 $0.31 $0.39 48% 18% Diluted EPS, excluding charges & credits* $0.46 $0.43 $0.42 7% 10% North America revenue $3,189 $3,139 $2,602 2% 23% International revenue $5,215 $5,065 $5,147 3% 1% North America revenue, excluding Cameron $2,572 $2,546 $2,086 1% 23% International revenue, excluding Cameron $4,559 $4,387 $4,430 4% 3% *These are non-GAAP financial measures. See section below entitled "Charges & Credits" for details. Schlumberger Chairman and CEO Paal Kibsgaard commented, “Our third

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme